Newsletter | February 11, 2021

02.11.21 -- The Second Wave Of Biosimilars: New Scenarios, New Rules

 
Sponsor
Featured Editorial
Industry Insights
Is Your Sterile Injectable Ready For Changes In Raw Materials?

Changes in raw materials are inevitable over a drug's lifespan, but even small modifications can throw your drug out of compliance. Learn how to safeguard drug integrity when raw materials change.

Effectively Managing Data In Process Development

Addressing data management challenges during drug development calls for a deeper understanding of the shortcomings of today’s methods and the factors you need to consider when adopting a solution to overcome them.

Save Time, Cut Costs With Process Transfer For Biologics Production

Explore a novel scale conversion tool for transferring parameters to predict the best set of cell culture parameters for single-use stirred-tank bioreactors from development to manufacturing scale.

News Headlines
Solutions
Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.